New Drug May Provide More Cost-Effective Stroke Prevention than Warfarin, Stanford University School of Medicine/Veterans Affairs Medical Center Study Shows  
11/2/2010 6:14:12 AM

EurekAlert! -- STANFORD, Calif. — A newly approved drug may be a cost-effective way to prevent stroke in patients with an irregular heart rhythm — and may also offer patients better health outcomes than the commonly prescribed, but potentially risky, blood thinner warfarin. That's according to a new analysis from researchers at the Stanford University School of Medicine and the Veterans Affairs Palo Alto Health Care System.